Protection by indomethacin and aspirin against genotoxicity of ochratoxin A, particularly in the urinary bladder and kidney

Archives of Toxicology

Volumn 70, Issue 3-4, 1996, Pages 244-248

  Obrecht Pflumio, S ^a   Grosse, Y ^b   Pfohl Leszkowicz, A ^b   Dirheimer, G ^a  

^a INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

Author keywords

Balkan endemic nephropathy; DNA adducts; Mycotoxin; Ochratoxin A; Prostaglandin H synthase

Indexed keywords

ACETYLSALICYLIC ACID; INDOMETACIN; OCHRATOXIN; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; CONTROLLED STUDY; DNA ADDUCT; GENOTOXICITY; KIDNEY; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; TESTIS;

ANIMALS; ANTICARCINOGENIC AGENTS; ASPIRIN; DNA ADDUCTS; DNA DAMAGE; INDOMETHACIN; KIDNEY; KIDNEY NEOPLASMS; MALE; MICE; OCHRATOXINS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

ANIMALIA;

EID: 0030050658     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040050267     Document Type: Article

References (41)

1. Battista JR, Marnett LJ (1985) Prostaglandin H synthase-dependant oxidation of aflatoxin Bl. Carcinogenesis 6: 1227-1229
2. Bendele AM, Carlton WW, Krogh P, Lillehoj EB (1985) Ochratoxin A carcinogenesis in the (C57BL/6JxC3H)F1 mouse. J Natl Cancer Inst 75: 733-742
3. Castegnaro M, Chernozemsky IN, Hietanen E, Bartsch H (1990) Are mycotoxins risk factors for endemic nephropathy and associated urothelial cancers? Arch Geschwulstforsch 60: 295-303
4. Ceovic S, Plestina R, Miletic-Medved M, Stavljenic A, Mitar J, Vukelic M (1991) Epidemiological aspects of Balkan endemic nephropathy in a typical focus in Yugoslavia. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H (eds) Mycotoxin, endemic nephropathy and urinary tract tumours. IARC Scientific Publications vol. 115, International Agency for Research on Cancer, Lyon, pp 5-10
5. Christ EJ, Van Dorp DA (1972) Comparative aspects of prostaglandin biosynthesis in animal tissue. Biochim Biophys Acta 270: 537-545
6. Creppy EE, Betbeder AM, Gharbi A, Gauret MF, Andrieux M, Counord J, Bartsch H, Castegnaro M, Fouillet B, Chambon P, Grosse Y, Pfohl-Leszkowicz A, Dirheimer G, Mériaux J, Guiot-Guillain M, Douet C, Manier C, Giacomotto P, Vezon G, Montcharmont P, Waller JP, Laustriat D, Cazenave JP (1993) Etude de l'ochratoxicose humaine dans trois regions de France: Alsace, Aquitaine et région Rhône-Alpes. In: Creppy EE, Castegnaro M, Dirheimer G (eds) Human ochratoxicosis and its pathologies. Les Editions INSERM, vol. 231, John Libbey Eurotext, Montrouge, pp 147-158
7. Degen GH (1990) Role of protaglandin-H synthase in mediating genotoxic and carcinogenic effects of estrogens. Environ Health Perspect 88: 217-223
8. Delacruz L, Bach PH (1990) The role of ochratoxin A metabolism and biochemistry in animal and human nephrotoxicity. J Biopharmaceut Sci 1: 277-304
9. Dirheimer G, Creppy EE (1991) Mechanism of action of ochratoxin A. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H (eds) Mycotoxin, endemic nephropathy and urinary tract tumours. IARC Scientific Publications, vol. 115, International Agency for Research on Cancer, Lyon. pp 171-186
10. Eling T, Boyd J, Reed G, Mason R, Sivarajah K (1983) Xenobiotic metabolism by prostaglandin endoperoxide synthetase. Drug Metab Rev 14: 1023-1053
11. Eling TE, Thompson DC, Foureman GL, Curtis J, Hughes MF (1990) Prostaglandin H synthase and xenobiotic oxidation. Annu Rev Pharmacol Toxicol 30: 1-45
12. Föllmann W, Hillebrand IE, Creppy EE, Bolt HM (1995) Sister chromatid exchange frequency in cultured isolated porcine urinary bladder epithelial cells (PUBEC) treated with ochratoxin A and alpha. Arch Toxicol 69: 280-286
13. Hald B (1991) Ochratoxin A in human blood in European countries. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H (eds) Mycotoxin, endemic nephropathy and urinary tract tumours. IARC Scientific Publications, vol. 115, International Agency for Research on Cancer, Lyon, pp 159-164
14. Holmberg T, Hagelberg S, Lundenheim N, Thafvelin B, Hult K (1990) Ochratoxin A in swine blood used for evaluation of cereal handling procedures. J Vet Med B 37: 97-105
15. Hult K, Plestina R, Habazin-Novak V, Rodic B, Leovic S (1982) Ochratoxin A in human blood and Balkan endemic nephropathy. Arch Toxicol 51: 313-321
16. Kanisawa M, Suzuki S (1978) Induction of renal and hepatic tumors in mice by ochratoxin A, a mycotoxin. Gann 69: 599-600
17. Krogh P (1987) Ochratoxins in food. In: Krogh P (ed) Mycotoxins in food. Academic Press, London, pp 97-121
18. Kuiper-Goodman T, Scott PM (1989) Risk assessment of the mycotoxin ochratoxin A. Biomed Environ Sci 2: 179-248
19. Liu L, Massey TE (1992) Bioactivation of aflatoxin B1 by lipoxygenases, prostaglandin H synthase and cytochrome P450 monooxygenase in guinea-pig tissues. Carcinogenesis 13: 533-539
20. Marnett LJ, Eling TE (1983) Cooxidation during prostaglandin biosynthesis: a pathway for the metabolic activation of xenobiotics. Rev Biochem Toxicol 5: 135-172
21. Merwe KJ van der, Steyn PS, Fourie L, Scott DB, Theron JJ (1965) Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus Wilh. Nature 205: 1112-1113
22. Moncada S, Vane JR (1979) Pharmacology and endogenous role of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev 30: 293-331
23. NTP (1988) Technical report on the toxicology and carcinogenesis studies of ochratoxin A (CAS No 303-47-9) in F344/N rats (gavage studies). NIH Publication No. 89-2813, US Dept of Health and Human Services, National Institutes of Health, Research Triangle Park, N. C.
24. Oster T, Jayyosi Z, Creppy EE, El Amri HS, Batt AM (1991) Characterization of pig liver purified cytochrome P450 isoenzymes for ochratoxin A metabolism studies. Toxicol Lett 57: 203-214
25. Petkova-Bocharova T, Chernozemsky IN, Castegnaro M (1988) Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary system tumours in Bulgaria. Food Addit Contam 5: 299-301
26. Pfohl-Leszkowicz A, Chakor K, Creppy EE, Dirheimer G (1991) DNA adduct formation in mice after treatment with ochratoxin A. In: Castegnaro M, Plestina II, Dirheimer G, Chernozemsky IN, Bartsch H (eds) Mycotoxin, endemic nephropathy and urinary tract tumours. IARC Science Publications, vol. 115, International Agency for Research on Cancer, Lyon, pp 245-254
27. Pfohl-Leszkowicz A, Grosse Y, Kane A, Creppy EE, Dirheimer G (1993a) Differential DNA adduct formation and disappearance in the mouse tissues after treatment with the mycotoxin ochratoxin A. Mutat Res 289: 265-273
28. Pfohl-Leszkowicz A, Grosse Y, Kane A, Gharbi A, Baudrimont I, Obrecht S, Creppy EE, Dirheimer G (1993b) Is the oxidative pathway implicated in the genotoxicity of ochratoxin A? In: Creppy EE, Castegnaro M, Dirheimer G (eds) Human ochratoxicosis and its pathologies. Les Editions INSERM, vol. 231, John Libbey Eurotext. Montrouge, pp 177-187
29. Pfohl-Leszkowicz A, Grosse Y, Castegnaro M, Nicolov IG, Chernozemsky IN, Bartsch H, Betbeder AM, Creppy EE, Dirheimer G (1993c) Ochratoxin A-related DNA adducts in urinary tract tumours of Bulgarian subjects. In: Phillips DH, Castegnaro M, Bartsch H (eds) Postlabelling methods for detection of DNA adducts. IARC Scientific Publications, vol. 124. International Agency for Research on Cancer, Lyon, pp 141-148
30. Pfohl-Leszkowicz A, Obrecht S, Grosse Y, Dirheimer G (1994) Involvement of antioxidants and inhibitors of glulathione conjugation in ochratoxin A genotoxicity in mice liver and kidney. Toxicol Lett 74 [suppl 1]: 65
31. Pfohl-Leszkowicz A, Grosse Y, Obrecht S, Kane A, Castegnaro M, Creppy EE, Dirheimer G (1993d) Preponderance of DNA-adducts in kidney after ochratoxin A exposure. In: Creppy EE, Castegnaro M, Dirheimer G (eds) Human ochratoxicosis and its pathologies. Les Editions INSERM, vol. 231, John Libbey Eurotext, Montrouge, pp 199-207
32. Pohland AE (1993) Mycotoxins in review. Food Addit Contamin 10: 17-28
33. Pohland AE, Nesheim S, Friedman L (1992) Ochratoxin A: a review. Pure Appl Chem 64; 1029-1046
34. 32P-postlabelling test for structurally diverse DNA adducts. Carcinogenesis 7: 1543-1551
35. Sivarajah K, Lasker JM, Eling TE (1981) Prostaglandin synthetase-dependent cooxidation of (±)-benzo[a]pyrene-7,8-dihydrodiol by human lung and other mammalian tissues. Cancer Res 41: 1834-1839
36. Smith WL, Marnett LJ (1991) Prostaglandin endoperoxide synthase: structure and catalyses. Biochim Biophys Acta 1083: 1-17
37. Sostaric B, Vukelic M (1991) Characteristics of urinary tract tumours in the area of Balkan endemic nephropathy in Croatia. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H (eds) Mycotoxin, endemic nephropathy and urinary tract tumours. IARC Science Publication, vol. 115, International Agency for Research on Cancer, Lyon, pp 29-35
38. Speijers GJA, Egmond van HP (1993) Worldwide ochratoxin A levels in food and feeds. In: Creppy EE, Castegnaro M, Dirheimer G (eds) Human ochratoxicosis and its pathologies. Les Editions INSERM, vol. 231, John Libbey Eurotext, Montrouge, pp 85-100
39. Størmer FC (1992) Ochratoxin A, a mycotoxin of concern. In: Bhatnagar D, Lillehoj EB, Arora DK (eds) Mycotoxins in ecological systems. Handbook of Applied Mycology, Marcel Dekker, New York, pp 403-432
40. Ueno Y (1985) Biotransformation of mycotoxins in the reconstituted cytochrome P450 system. Proc Jpn Assoc Mycotox 22: 28-30
41. Zenser TV, Davis BB (1990) Oxidation of xenobiotics by prostaglandin H synthase. In: Goldstein RS, Hewitt WR, Hook JB (eds) Toxic interactions. Academic Press, San Diego, pp 61-86